GlassScriptPhysician profile
Charles L Elliott
NPI 1144226317
$16,580.37
in general payments reported to CMS, 2019-2025
19 companies · $9,608 in 2025
The $9,608 reported for 2025 was more than what 97% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $995 · 2021: $629 · 2022: $1,199 · 2023: $2,310 · 2024: $1,221 · 2025: $9,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Food and Beverage: $4,911 · Travel and Lodging: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Food and Beverage | $4,911.09 |
| Travel and Lodging | $727.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spirair, INC. | $9,993.38 | 2024-2025 | Septalign |
| Aerin Medical INC. | $3,856.57 | 2020-2025 | |
| Stryker Corporation | $739.07 | 2019-2023 | Xpress Ent Dilation System |
| Acclarent, INC | $659.34 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus, Acclarent Aera |
| Astrazeneca Pharmaceuticals LP | $386.26 | 2019-2024 | Airsupra, Breztri |
| Integra Lifesciences Corporation | $314.54 | 2024-2025 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Optinose US, INC. | $220.42 | 2019-2020 | |
| Genzyme Corporation | $90.10 | 2020-2025 | |
| Smith+Nephew, INC. | $66.19 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $53.94 | 2019 | |
| Glaxosmithkline, LLC. | $49.81 | 2024 | Nucala |
| Kaleo, INC. | $35.02 | 2019-2020 | |
| Amgen INC. | $31.58 | 2019 | |
| Daiichi Sankyo INC. | $17.36 | 2019 | |
| Merck Sharp & Dohme LLC | $15.85 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $13.76 | 2019 | |
| Pfizer INC. | $13.15 | 2019 | |
| Circassia INC. | $12.22 | 2019 | |
| Hologic Sales and Service, LLC | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.